Clinician Quiz: Recommendations on Treatment Approaches for Eating Disorders

Quiz
Article

Check your knowledge on the American Psychiatric Association 2023 practice guideline for the treatment of patients with eating disorders.

The American Psychiatric Association Practice Guideline for The Treatment of Patients With Eating Disorder, Fourth Edition (2023) provides recommendations for the treatment of various eating disorders. The guideline suggests individualized goals for weight gain and target weight in anorexia nervosa, eating disorder-focused psychotherapy for adults with anorexia nervosa, and family-based treatment for adolescents with anorexia nervosa.

For bulimia nervosa, cognitive-behavioral therapy and a serotonin reuptake inhibitor are recommended for adults and family-based treatment is suggested for adolescents. Patients with binge-eating disorder are recommended to receive cognitive-behavioral therapy, interpersonal therapy, or medication if psychotherapy alone is not effective. The guideline underlines the importance of personalized treatment plans and a multidisciplinary approach to address the physical and psychological aspects of eating disorders.

Test your knowledge of treatment guidelines for eating disorders with this clinician quiz:

According to the APA Practice Guideline for Eating Disorders, what is the recommended first-line treatment for adults with anorexia nervosa?


References

The American Psychiatric Association Practice Guideline For The Treatment Of Patients With Eating Disorders, Fourth Edition. American Psychiatric Association. 2023. https://psychiatryonline.org/doi/book/10.1176/appi.books.9780890424865. Accessed February 23, 2024.

Related Videos
Manish Jha, MD: Treatment Options for Treatment-Resistant Depression
Katharine Phillips, MD: Differences Between OCD, Body Dysmorphic Disorder
Brian Barnett, MD: Psychedelics Fitting into the SUDs Treatment Paradigm
Lenard A. Adler, MD: “Symptoms of ADHD Need to Go Back to Childhood”
3 Barriers to Improving Clozapine Use in Treatment-Resistant Schizophrenia
Evaluating MM120 for GAD with Daniel Karlin, MD, and Reid Robinson, MD, MBA
Daniel Karlin, MD: Prevalence of Undiagnosed Generalized Anxiety Disorder
The Future of DSM-5-TR with APA Members Nitin Gogtay, Maria Oquendo, Jonathan Alpert
Paul Appelbaum, MD: What to Warn Patients When Prescribing Psychedelics in the Future
© 2024 MJH Life Sciences

All rights reserved.